Product
Caffeine anhydrous
1 clinical trial
1 indication
Indication
Breast CarcinomaClinical trial
A Phase 1, Randomized, Double Blinded, Placebo Controlled Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation TherapyStatus: Active (not recruiting), Estimated PCD: 2024-04-01